Sort   by:  
 Page size 
UnknownCombined Microsatellite Instability, MLH1 Methylation Analysis, and Immunohistochemistry for Lynch Syndrome Screening in Endometrial Cancers From GOG210: An NRG Oncology and Gynecologic Oncology Group Study.
Not available
S-EPMC4678181 | biostudies-literature
UnknownA randomized, placebo-controlled trial of canakinumab in patients with peripheral artery disease.
Not available
S-EPMC6791746 | biostudies-literature
UnknownCereblon harnesses Myc-dependent bioenergetics and activity of CD8+ T lymphocytes.
Not available
S-EPMC7426646 | biostudies-literature
UnknownCD4 receptor diversity in chimpanzees protects against SIV infection.
Not available
S-EPMC6386711 | biostudies-literature
UnknownTherapeutic Anticoagulation with Heparin in Noncritically Ill Patients with Covid-19.
Not available
S-EPMC8362594 | biostudies-literature
UnknownTocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.
Not available
S-EPMC8084355 | biostudies-literature
UnknownSafety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK.
Not available
S-EPMC7723445 | biostudies-literature
UnknownPartnership for Research on Ebola VACcination (PREVAC): protocol of a randomized, double-blind, placebo-controlled phase 2 clinical trial evaluating three vaccine strategies against Ebola in healthy volunteers in four West African countries.
Not available
S-EPMC7823170 | biostudies-literature
UnknownImmunogenicity and Vaccine Shedding After 1 or 2 Doses of rVSVΔG-ZEBOV-GP Ebola Vaccine (ERVEBO®): Results From a Phase 2, Randomized, Placebo-controlled Trial in Children and Adults.
Not available
S-EPMC11006114 | biostudies-literature
UnknownLong-term cellular immunity of vaccines for Zaire Ebola Virus Diseases.
Not available
S-EPMC11372064 | biostudies-literature
Sort   by:  
 Page size